Pharmacological approaches to cystic fibrosis

Eur J Med Chem. 2021 Apr 15:216:113240. doi: 10.1016/j.ejmech.2021.113240. Epub 2021 Jan 30.

Authors

Tiziano Bandiera¹, Luis J V Galietta²

Affiliations

¹ D3 PharmaChemistry Line, Istituto Italiano di Tecnologia, via Morego 30, 16163, Genoa, Italy. Electronic address: Tiziano.Bandiera@iit.it.
² Telethon Institute of Genetics and Medicine (TIGEM), Campi Flegrei 34, 80078, Pozzuoli, NA, Italy; Department of Translational Medical Sciences (DISMET), University of Naples, "Federico II", Via Sergio Pansini 5, 80131, Naples, Italy.

PMID: 33691259
DOI: 10.1016/j.ejmech.2021.113240

No abstract available

Publication types

Editorial

MeSH terms

Cystic Fibrosis / drug therapy*
Cystic Fibrosis / genetics
Cystic Fibrosis / metabolism
Cystic Fibrosis Transmembrane Conductance Regulator / genetics
Cystic Fibrosis Transmembrane Conductance Regulator / metabolism
Humans
Molecular Targeted Therapy
Mutation

Substances

Cystic Fibrosis Transmembrane Conductance Regulator